About OXOS Medical
OXOS Medical is a Healthcare company based in Atlanta (United States) founded in 2001 by Gregory Kolovich and Evan Ruff. Orthopedic imaging devices and software are developed for surgical use. OXOS Medical has raised $53.17 million across 9 funding rounds from investors including Parkway VC and Intel Capital. Its chief executive, as recorded, is Evan Ruff. OXOS Medical offers products and services including MC2 Solutions, MC2 Clinic, MC2 LE, MC2 Go, and MC2 Lab. Its focus areas include Life Sciences, Imaging Diagnostics, X-Ray Radiography and Orthopedics.
Company details
OXOS Medical was founded in 2001 and is based in Atlanta, United States. Focus is placed on the medical devices sector, where orthopedic imaging devices and software are created. Operations center on producing a handheld fluoroscopy device called Micro C, which allows images of extremities to be captured during orthopedic procedures by surgeons and physicians.
- Total Equity Funding$53.17M (USD)
in 9 rounds
- Latest Funding Round$10.71M (USD), Series A
Dec 2025
- InvestorsParkway VC
& 1 more
Products & Services of OXOS Medical
OXOS Medical offers a comprehensive portfolio of products and services, including MC2 Solutions, MC2 Clinic, MC2 LE, MC2 Go, and MC2 Lab.
Portable system for medical imaging with low radiation
Modular tool for clinical settings diagnostics
Device for specialized extremity imaging
Portable solution for mobile medical use
System for laboratory-based imaging applications
Funding Insights of OXOS Medical
OXOS Medical has successfully raised a total of $53.17M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $10.71 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $53.17M
- Total Rounds 9
- Last Round Series A — $10.71M
- First Round $260,000
(Jul 2016)
- Investors Count 2
All 9 funding rounds of OXOS Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2025 | $10.71M | Series A | – | – | – |
| Apr 2023 | $23M | Series A | – | Parkway VC, Intel Capital | – |
| Feb 2022 | $8.17M | Series A | – | – | – |
| Feb 2021 | $4.4M | Series A | – | – | – |
| Feb 2020 | $4.78M | Series A | – | – | – |
| Mar 2018 | $1M | Seed | – | – | – |
| Aug 2017 | $150,000 | Seed | – | – | – |
| Jan 2017 | $700,000 | Seed | – | – | – |
| Jul 2016 | $260,000 | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in OXOS Medical
OXOS Medical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Parkway VC and Intel Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are provided to disruptive technology startups. | parkway.vc | New York, USA | ||
Investment in technology startups focusing on compute, AI, and related innovations. | intelcapital.com |
Investor details for OXOS Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OXOS Medical
21 people are tracked at OXOS Medical (9 in leadership, 3 in board & advisors, 9 in team).
| Name | Role | Group |
|---|---|---|
Gregory Kolovich | Co-Founder & CMO | Leadership |
Evan Ruff | Co-Founder & CEO | Leadership |
Evan M. Ruff | CEO & Co-Founder | Leadership |
Gregory P. Kolovich | Chief Medical Officer & Co-Founder | Leadership |
Dev Mandavia | Vp, Strategy And Corporate Development | Leadership |
Mary Jenkins | Human Resources Director | Leadership |
Jonathan Shaw | Director, Sales | Leadership |
Youssra Marjoua | International Medicine Chief | Leadership |
Mo Khosravanipour | Director, Operations | Leadership |
Charlie Bourland Iii | Member | Board & advisors |
Andy Thorson | Member | Board & advisors |
James Stubbs | Member | Board & advisors |
Amy Culbertson | Regional Sales Manager, Southeast | Team |
Jordan Perkins | Medical Device Sales Representative - RDS | Team |
Greg Carpenter | OXOS Medical Sales Distributor | Team |
Emma Hagerty | Technical Solutions Engineer | Team |
Megan P. | Quality Manager | Team |
Douglas Borkowski | Business Development Leader, US | Team |
Tom Lombardo | Enterprise Solutions Lead | Team |
Will Sharon | Manager, Strategy & Analytics | Team |
1 more people are available in the full profile.
Complete people profiles for OXOS Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OXOS Medical
3 dated milestones of OXOS Medical across 24 years, from founding to its latest funding, stage changes and deals.
- Founded OXOS Medical is founded.
- Funding First funding round of $260K.
- Funding Latest funding round, Series A, of $10.7M.
Web traffic of OXOS Medical
The website of OXOS Medical (oxos.com) receives about 4.1K visits a month.
- Monthly visits4.1K
▲ 0.5% vs previous month
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as OXOS Medical (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oxos Medical
Complete news archive for OXOS Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OXOS Medical
OXOS Medical was founded in 2001 and raised its 1st funding round 15 years after it was founded.
OXOS Medical is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Evan Ruff is the CEO of OXOS Medical, as recorded in our data. They have also founded this company.
OXOS Medical is a funded company, having raised a total of $53.17M across 9 funding rounds to date. The company's 1st funding round was a Seed of $260K, raised on Jul 2016.
OXOS Medical was founded in 2001 and is based in Atlanta, United States. Focus is placed on the medical devices sector, where orthopedic imaging devices and software are created. Operations center on producing a handheld fluoroscopy device called Micro C, which allows images of extremities to be captured during orthopedic procedures by surgeons and physicians.
OXOS Medical offers MC2 Solutions, MC2 Clinic, MC2 LE, MC2 Go, and MC2 Lab.
OXOS Medical has 2 investors. Key investors include Parkway VC, and Intel Capital.